The Michigan Cancer Research Consortium (MCRC) is a network of medical centers conducting cancer clinical trials, with sites in Michigan, Pennsylvania, and Florida. MCRC has a strong scientific presence, with expertise in various cancer areas, and is committed to ensuring high-quality research and patient care. The consortium is undergoing leadership changes, with Dr. Al baghdadi as the new PI and Dr. Juhasz as the new director of oncology research.

Read the Full Article